Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2018 | How reliable is NGS in diagnosing AML?

Christopher Gibson • 12 Sep 2018
SOHO 2018
Acute Myeloid Leukemia Leukemia

Christopher Gibson, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses the reliability of next-generation sequencing (NGS) at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX. Dr Gibson explains that results from NGS have been reliable as the mutations seen are those that are present in Acute myeloid leukemia (AML). Dr Gibson also questions the relevance on the results and how this is entirely dependent on expert interpretation.

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Christopher Gibson

The superior sequencing technique: NGS versus SGS
1:42
The superior sequencing technique: NGS versus SGS
Christopher Gibson • 12 Sep 2018
Uses of NGS in AML
3:11
Uses of NGS in AML
Christopher Gibson • 12 Sep 2018
Pros and cons of next-generation sequencing
3:40
Pros and cons of next-generation sequencing
Christopher Gibson • 12 Sep 2018

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals